{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:06:04Z","timestamp":1793675164916,"version":"4.5.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI137324"],"award-info":[{"award-number":["R01AI137324"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Breast cancer is the most common cancer in women diagnosed in the U.S. and worldwide. Obesity increases breast cancer risk without clear underlying molecular mechanisms. Our studies demonstrate that circulating adipose fatty acid binding protein (A-FABP, or FABP4) links obesity-induced dysregulated lipid metabolism and breast cancer risk, thus potentially offering a new target for breast cancer treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We immunized FABP4 knockout mice with recombinant human FABP4 and screened hybridoma clones with specific binding to FABP4. The potential effects of antibodies on breast cancer cells in vitro were evaluated using migration, invasion, and limiting dilution assays. Tumor progression in vivo was evaluated in various types of tumorigenesis models including C57BL\/6 mice, Balb\/c mice, and SCID mice. The phenotype and function of immune cells in tumor microenvironment were characterized with multi-color flow cytometry. Tumor stemness was detected by ALDH assays. To characterize antigen-antibody binding capacity, we determined the dissociation constant of selected anti-FABP4 antibodies via surface plasmon resonance. Further analyses in tumor tissue were performed using 10X Genomics Visium spatial single cell technology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Herein, we report the generation of humanized monoclonal antibodies blocking FABP4 activity for breast cancer treatment in mouse models. One clone, named 12G2, which significantly reduced circulating levels of FABP4 and inhibited mammary tumor growth, was selected for further characterization. After confirming the therapeutic efficacy of the chimeric 12G2 monoclonal antibody consisting of mouse variable regions and human IgG1 constant regions, 16 humanized 12G2 monoclonal antibody variants were generated by grafting its complementary determining regions to selected human germline sequences. Humanized V9 monoclonal antibody showed consistent results in inhibiting mammary tumor growth and metastasis by affecting tumor cell mitochondrial metabolism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our current evidence suggests that targeting FABP4 with humanized monoclonal antibodies may represent a novel strategy for the treatment of breast cancer and possibly other obesity- associated diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13058-024-01873-y","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T05:02:43Z","timestamp":1721883763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Development of a humanized anti-FABP4 monoclonal antibody for potential treatment of breast cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Jiaqing","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingshan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Schnicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Chimenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia L.","family":"Sugg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,25]]},"reference":[{"key":"1873_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, Vignat J, Gralow JR, Cardoso F, Siesling S, Soerjomataram I. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast. 2022;66:15\u201323. PubMed PMID: 36084384; PMCID: PMC9465273.","journal-title":"Breast"},{"key":"1873_CR2","doi-asserted-by":"publisher","first-page":"100985","DOI":"10.1016\/j.eclinm.2021.100985","volume":"38","author":"SM Lima","year":"2021","unstructured":"Lima SM, Kehm RD, Terry MB. Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns. EClinicalMedicine. 2021;38:100985. https:\/\/doi.org\/10.1016\/j.eclinm.2021.100985. Epub 20210707.","journal-title":"EClinicalMedicine"},{"issue":"2","key":"1873_CR3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41576-021-00414-z","volume":"23","author":"RJF Loos","year":"2022","unstructured":"Loos RJF, Yeo GSH. The genetics of obesity: from discovery to biology. Nat Rev Genet. 2022;23(2):120\u201333. https:\/\/doi.org\/10.1038\/s41576-021-00414-z. Epub 20210923.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"1873_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/bmb\/ldx022","volume":"123","author":"D Albuquerque","year":"2017","unstructured":"Albuquerque D, Nobrega C, Manco L, Padez C. The contribution of genetics and environment to obesity. Br Med Bull. 2017;123(1):159\u201373. https:\/\/doi.org\/10.1093\/bmb\/ldx022. PubMed PMID: 28910990.","journal-title":"Br Med Bull"},{"key":"1873_CR5","doi-asserted-by":"publisher","unstructured":"Buckley J. Availability of high-fat foods might drive the obesity epidemic. Nat Rev Endocrinol. 2018;14(10):574-5. https:\/\/doi.org\/10.1038\/s41574-018-0084-3. PubMed PMID: 30158548.","DOI":"10.1038\/s41574-018-0084-3"},{"key":"1873_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.06.010","author":"S Hu","year":"2018","unstructured":"Hu S, Wang L, Yang D, Li L, Togo J, Wu Y, Liu Q, Li B, Li M, Wang G, Zhang X, Niu C, Li J, Xu Y, Couper E, Whittington-Davies A, Mazidi M, Luo L, Wang S, Douglas A, Speakman JR. Dietary Fat, but Not Protein or Carbohydrate, Regulates Energy Intake and Causes Adiposity in Mice. Cell Metab. 2018;28(3):415\u2013. https:\/\/doi.org\/10.1016\/j.cmet.2018.06.010. Epub 2018\/07\/19. \u200931 e4."},{"issue":"4","key":"1873_CR7","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/MCO.0b013e32833aabef","volume":"13","author":"MJ Lee","year":"2010","unstructured":"Lee MJ, Wu Y, Fried SK. Adipose tissue remodeling in pathophysiology of obesity. Curr Opin Clin Nutr Metab Care. 2010;13(4):371\u20136. https:\/\/doi.org\/10.1097\/MCO.0b013e32833aabef. PubMed PMID: 20531178; PMCID: PMC3235038. Epub 2010\/06\/10.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"12","key":"1873_CR8","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/nrc3174","volume":"11","author":"MJ Khandekar","year":"2011","unstructured":"Khandekar MJ, Cohen P, Spiegelman BM. Molecular mechanisms of cancer development in obesity. Nat Rev Cancer. 2011;11(12):886\u201395. https:\/\/doi.org\/10.1038\/nrc3174. Epub 2011\/11\/25.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"1873_CR9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3322\/caac.21405","volume":"67","author":"M Picon-Ruiz","year":"2017","unstructured":"Picon-Ruiz M, Morata-Tarifa C, Valle-Goffin JJ, Friedman ER, Slingerland JM. Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention. CA Cancer J Clin. 2017;67(5):378\u201397. PubMed PMID: 28763097; PMCID: PMC5591063.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"1873_CR10","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S1470-2045(02)00849-5","volume":"3","author":"F Bianchini","year":"2002","unstructured":"Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol. 2002;3(9):565\u201374. Epub 2002\/09\/10. doi: https:\/\/doi.org\/10.1016\/s1470-2045(02)00849-5. PubMed PMID: 12217794.","journal-title":"Lancet Oncol"},{"issue":"8","key":"1873_CR11","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrc1408","volume":"4","author":"EE Calle","year":"2004","unstructured":"Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4(8):579\u201391. https:\/\/doi.org\/10.1038\/nrc1408. Epub 2004\/08\/03.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"1873_CR12","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.bbalip.2013.02.008","volume":"1831","author":"SM Louie","year":"2013","unstructured":"Louie SM, Roberts LS, Nomura DK. Mechanisms linking obesity and cancer. Biochim Biophys Acta. 2013;1831(10):1499\u2013508. https:\/\/doi.org\/10.1016\/j.bbalip.2013.02.008. Epub 20130305.","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"1873_CR13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrendo.2014.94","volume":"10","author":"J Park","year":"2014","unstructured":"Park J, Morley TS, Kim M, Clegg DJ, Scherer PE. Obesity and cancer\u2013mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol. 2014;10(8):455\u201365. https:\/\/doi.org\/10.1038\/nrendo.2014.94. Epub 20140617.","journal-title":"Nat Rev Endocrinol"},{"key":"1873_CR14","doi-asserted-by":"publisher","unstructured":"Roberts DL, Dive C, Renehan AG. Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med. 2010;61:301\u201316. https:\/\/doi.org\/10.1146\/annurev.med.080708.082713. PubMed PMID: 19824817.","DOI":"10.1146\/annurev.med.080708.082713"},{"issue":"5","key":"1873_CR15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.molmed.2020.03.004","volume":"26","author":"J Zeng","year":"2020","unstructured":"Zeng J, Sauter ER, Li B. FABP4: a new player in obesity-Associated breast Cancer. Trends Mol Med. 2020;26(5):437\u201340. https:\/\/doi.org\/10.1016\/j.molmed.2020.03.004. Epub 2020\/05\/04.","journal-title":"Trends Mol Med"},{"issue":"5","key":"1873_CR16","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.cmet.2018.07.006","volume":"28","author":"J Hao","year":"2018","unstructured":"Hao J, Zhang Y, Yan X, Yan F, Sun Y, Zeng J, Waigel S, Yin Y, Fraig MM, Egilmez NK, Suttles J, Kong M, Liu S, Cleary MP, Sauter E, Li B. Circulating adipose fatty acid binding protein is a New Link underlying obesity-Associated Breast\/Mammary Tumor Development. Cell Metab. 2018;28(5):689\u2013705. https:\/\/doi.org\/10.1016\/j.cmet.2018.07.006. e5. Epub 2018\/08\/14.","journal-title":"Cell Metab"},{"issue":"9","key":"1873_CR17","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1158\/0008-5472.CAN-17-2465","volume":"78","author":"J Hao","year":"2018","unstructured":"Hao J, Yan F, Zhang Y, Triplett A, Zhang Y, Schultz DA, Sun Y, Zeng J, Silverstein KAT, Zheng Q, Bernlohr DA, Cleary MP, Egilmez NK, Sauter E, Liu S, Suttles J, Li B. Expression of Adipocyte\/Macrophage fatty acid-binding protein in Tumor-Associated macrophages promotes breast Cancer Progression. Cancer Res. 2018;78(9):2343\u201355. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-2465. Epub 2018\/02\/14.","journal-title":"Cancer Res"},{"issue":"10","key":"1873_CR18","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nrendo.2015.122","volume":"11","author":"GS Hotamisligil","year":"2015","unstructured":"Hotamisligil GS, Bernlohr DA. Metabolic functions of FABPs\u2013mechanisms and therapeutic implications. Nat Rev Endocrinol. 2015;11(10):592\u2013605. https:\/\/doi.org\/10.1038\/nrendo.2015.122. Epub 2015\/08\/12.","journal-title":"Nat Rev Endocrinol"},{"key":"1873_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.07.027","author":"B Li","year":"2020","unstructured":"Li B, Hao J, Zeng J, Sauter ER, SnapShot:. FABP Funct Cell. 2020;182(4):1066. https:\/\/doi.org\/10.1016\/j.cell.2020.07.027. PubMed PMID: 32822569; PMCID: PMC7439965. - e1Epub 2020\/08\/22."},{"key":"1873_CR20","doi-asserted-by":"publisher","unstructured":"Hao J. Thermal Shift Assay for Exploring Interactions Between Fatty Acid-Binding Protein and Inhibitors. Methods Mol Biol. 2021;2261:395\u2013409. https:\/\/doi.org\/10.1007\/978-1-0716-1186-9_24. PubMed PMID: 33421003.","DOI":"10.1007\/978-1-0716-1186-9_24"},{"issue":"23","key":"1873_CR21","doi-asserted-by":"publisher","first-page":"20658","DOI":"10.1074\/jbc.M111.218941","volume":"286","author":"BC Loveless","year":"2011","unstructured":"Loveless BC, Mason JW, Sakurai T, Inoue N, Razavi M, Pearson TW, Boulanger MJ. Structural characterization and epitope mapping of the glutamic acid\/alanine-rich protein from Trypanosoma congolense: defining assembly on the parasite cell surface. J Biol Chem. 2011;286(23):20658\u201365. https:\/\/doi.org\/10.1074\/jbc.M111.218941. Epub 20110406.","journal-title":"J Biol Chem"},{"issue":"1","key":"1873_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0022-1759(90)90458-8","volume":"128","author":"F Perosa","year":"1990","unstructured":"Perosa F, Carbone R, Ferrone S, Dammacco F. Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphate. J Immunol Methods. 1990;128(1):9\u201316. https:\/\/doi.org\/10.1016\/0022-1759(90)90458-8. PubMed PMID: 2324507.","journal-title":"J Immunol Methods"},{"issue":"2","key":"1873_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0022-1759(87)90324-3","volume":"96","author":"MM McKinney","year":"1987","unstructured":"McKinney MM, Parkinson A. A simple, non-chromatographic procedure to purify immunoglobulins from serum and ascites fluid. J Immunol Methods. 1987;96(2):271\u20138. https:\/\/doi.org\/10.1016\/0022-1759(87)90324-3. PubMed PMID: 3805742.","journal-title":"J Immunol Methods"},{"issue":"9801","key":"1873_CR24","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/S0140-6736(11)61351-2","volume":"378","author":"MH Forouzanfar","year":"2011","unstructured":"Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, Naghavi M. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011;378(9801):1461\u201384. https:\/\/doi.org\/10.1016\/S0140-6736(11)61351-2. Epub 20110914.","journal-title":"Lancet"},{"issue":"20","key":"1873_CR25","doi-asserted-by":"publisher","first-page":"5296","DOI":"10.1158\/0008-5472.CAN-21-0757","volume":"81","author":"R Jin","year":"2021","unstructured":"Jin R, Hao J, Yi Y, Yin D, Hua Y, Li X, Bao H, Han X, Egilmez NK, Sauter ER, Li B. Dietary Fats High in Linoleic acids impair antitumor T-cell responses by inducing E-FABP-Mediated mitochondrial dysfunction. Cancer Res. 2021;81(20):5296\u2013310. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-0757. Epub 20210816.","journal-title":"Cancer Res"},{"issue":"12","key":"1873_CR26","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1158\/0008-5472.CAN-19-3184","volume":"80","author":"L Liu","year":"2020","unstructured":"Liu L, Jin R, Hao J, Zeng J, Yin D, Yi Y, Zhu M, Mandal A, Hua Y, Ng CK, Egilmez NK, Sauter ER, Li B. Consumption of the Fish Oil High-Fat Diet Uncouples Obesity and mammary tumor growth through induction of reactive oxygen species in Protumor Macrophages. Cancer Res. 2020;80(12):2564\u201374. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-3184. Epub 2020\/03\/28.","journal-title":"Cancer Res"},{"key":"1873_CR27","doi-asserted-by":"publisher","unstructured":"Hu Y, Smyth GK. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods. 2009;347(1\u20132):70\u2009\u2013\u20098. Epub 20090628. https:\/\/doi.org\/10.1016\/j.jim.2009.06.008. PubMed PMID: 19567251.","DOI":"10.1016\/j.jim.2009.06.008"},{"key":"1873_CR28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3389\/fonc.2018.00227","volume":"8","author":"CWS Tong","year":"2018","unstructured":"Tong CWS, Wu M, Cho WCS, To KKW. Recent advances in the treatment of breast Cancer. Front Oncol. 2018;8:227. Epub 20180614. doi: 10.3389\/fonc.2018.00227. PubMed PMID: 29963498; PMCID: PMC6010518.","journal-title":"Front Oncol"},{"issue":"3","key":"1873_CR29","doi-asserted-by":"publisher","first-page":"412","DOI":"10.5306\/wjco.v5.i3.412","volume":"5","author":"O Yersal","year":"2014","unstructured":"Yersal O, Barutca S. Biological subtypes of breast cancer: prognostic and therapeutic implications. World J Clin Oncol. 2014;5(3):412\u201324. https:\/\/doi.org\/10.5306\/wjco.v5.i3.412. PubMed PMID: 25114856; PMCID: PMC4127612.","journal-title":"World J Clin Oncol"},{"key":"1873_CR30","doi-asserted-by":"publisher","unstructured":"Waks AG, Winer EP. Breast Cancer Treatment: A Review. JAMA. 2019;321(3):288\u2013300. https:\/\/doi.org\/10.1001\/jama.2018.19323. PubMed PMID: 30667505.","DOI":"10.1001\/jama.2018.19323"},{"issue":"7635","key":"1873_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature20791","volume":"541","author":"G Pascual","year":"2017","unstructured":"Pascual G, Avgustinova A, Mejetta S, Martin M, Castellanos A, Attolini CS, Berenguer A, Prats N, Toll A, Hueto JA, Bescos C, Di Croce L, Benitah SA. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature. 2017;541(7635):41\u20135. https:\/\/doi.org\/10.1038\/nature20791. Epub 20161207.","journal-title":"Nature"},{"issue":"1","key":"1873_CR32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12943-017-0646-3","volume":"16","author":"X Luo","year":"2017","unstructured":"Luo X, Cheng C, Tan Z, Li N, Tang M, Yang L, Cao Y. Emerging roles of lipid metabolism in cancer metastasis. Mol Cancer. 2017;16(1):76. https:\/\/doi.org\/10.1186\/s12943-017-0646-3. Epub 20170411.","journal-title":"Mol Cancer"},{"issue":"12","key":"1873_CR33","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1016\/j.bmcl.2006.12.044","volume":"17","author":"R Sulsky","year":"2007","unstructured":"Sulsky R, Magnin DR, Huang Y, Simpkins L, Taunk P, Patel M, Zhu Y, Stouch TR, Bassolino-Klimas D, Parker R, Harrity T, Stoffel R, Taylor DS, Lavoie TB, Kish K, Jacobson BL, Sheriff S, Adam LP, Ewing WR, Robl JA. Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP). Bioorg Med Chem Lett. 2007;17(12):3511\u20135. https:\/\/doi.org\/10.1016\/j.bmcl.2006.12.044. Epub 20061221.","journal-title":"Bioorg Med Chem Lett"},{"issue":"7147","key":"1873_CR34","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nature05844","volume":"447","author":"M Furuhashi","year":"2007","unstructured":"Furuhashi M, Tuncman G, Gorgun CZ, Makowski L, Atsumi G, Vaillancourt E, Kono K, Babaev VR, Fazio S, Linton MF, Sulsky R, Robl JA, Parker RA, Hotamisligil GS. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature. 2007;447(7147):959\u201365. https:\/\/doi.org\/10.1038\/nature05844. Epub 2007\/06\/08.","journal-title":"Nature"},{"issue":"9","key":"1873_CR35","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s00424-017-1976-0","volume":"469","author":"Y Okamura","year":"2017","unstructured":"Okamura Y, Otani K, Sekiguchi A, Kogane T, Kakuda C, Sakamoto Y, Kodama T, Okada M, Yamawaki H. Vasculo-protective effect of BMS-309403 is independent of its specific inhibition of fatty acid-binding protein 4. Pflugers Arch. 2017;469(9):1177\u201388. https:\/\/doi.org\/10.1007\/s00424-017-1976-0. Epub 20170413.","journal-title":"Pflugers Arch"},{"issue":"8","key":"1873_CR36","doi-asserted-by":"publisher","first-page":"e44570","DOI":"10.1371\/journal.pone.0044570","volume":"7","author":"W Lin","year":"2012","unstructured":"Lin W, Huang X, Zhang L, Chen D, Wang D, Peng Q, Xu L, Li J, Liu X, Li K, Ding K, Jin S, Li J, Wu D. BMS309403 stimulates glucose uptake in myotubes through activation of AMP-activated protein kinase. PLoS ONE. 2012;7(8):e44570. https:\/\/doi.org\/10.1371\/journal.pone.0044570. Epub 20120831.","journal-title":"PLoS ONE"},{"issue":"3","key":"1873_CR37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00210-011-0667-1","volume":"384","author":"C Look","year":"2011","unstructured":"Look C, Morano I, Ehrhart-Bornstein M, Bornstein SR, Lamounier-Zepter V. BMS309403 directly suppresses cardiac contractile function. Naunyn Schmiedebergs Arch Pharmacol. 2011;384(3):255\u201363. https:\/\/doi.org\/10.1007\/s00210-011-0667-1. Epub 20110716.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"5","key":"1873_CR38","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.cmet.2013.04.012","volume":"17","author":"H Cao","year":"2013","unstructured":"Cao H, Sekiya M, Ertunc ME, Burak MF, Mayers JR, White A, Inouye K, Rickey LM, Ercal BC, Furuhashi M, Tuncman G, Hotamisligil GS. Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production. Cell Metab. 2013;17(5):768\u201378. PubMed PMID: 23663740; PMCID: PMC3755450.","journal-title":"Cell Metab"},{"issue":"319","key":"1873_CR39","doi-asserted-by":"publisher","first-page":"319ra205","DOI":"10.1126\/scitranslmed.aac6336","volume":"7","author":"MF Burak","year":"2015","unstructured":"Burak MF, Inouye KE, White A, Lee A, Tuncman G, Calay ES, Sekiya M, Tirosh A, Eguchi K, Birrane G, Lightwood D, Howells L, Odede G, Hailu H, West S, Garlish R, Neale H, Doyle C, Moore A, Hotamisligil GS. Development of a therapeutic monoclonal antibody that targets secreted fatty acid-binding protein aP2 to treat type 2 diabetes. Sci Transl Med. 2015;7(319):319ra205. https:\/\/doi.org\/10.1126\/scitranslmed.aac6336. Epub 2015\/12\/25.","journal-title":"Sci Transl Med"},{"issue":"12","key":"1873_CR40","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1002\/cam4.2474","volume":"8","author":"H Dillekas","year":"2019","unstructured":"Dillekas H, Rogers MS, Straume O. Are 90% of deaths from cancer caused by metastases? Cancer Med. 2019;8(12):5574\u20136. Epub 20190808. doi: https:\/\/doi.org\/10.1002\/cam4.2474. PubMed PMID: 31397113; PMCID: PMC6745820.","journal-title":"Cancer Med"},{"issue":"8","key":"1873_CR41","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.neo.2015.08.005","volume":"17","author":"RV Simoes","year":"2015","unstructured":"Simoes RV, Serganova IS, Kruchevsky N, Leftin A, Shestov AA, Thaler HT, Sukenick G, Locasale JW, Blasberg RG, Koutcher JA, Ackerstaff E. Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment. Neoplasia. 2015;17(8):671\u201384. PubMed PMID: 26408259; PMCID: PMC4674487.","journal-title":"Neoplasia"},{"key":"1873_CR42","doi-asserted-by":"crossref","unstructured":"Powell-Wiley TM, Poirier P, Burke LE, Despres JP, Gordon-Larsen P, Lavie CJ, Lear SA, Ndumele CE, Neeland IJ, Sanders P, St-Onge MP, American Heart Association Council on L, Cardiometabolic H, Council C, Stroke N. Council on Clinical C, Council on E, Prevention, Stroke C. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021;143(21):e984-e1010. Epub 20210422. doi: https:\/\/doi.org\/10.1161\/CIR.0000000000000973. PubMed PMID: 33882682; PMCID: PMC8493650.","DOI":"10.1161\/CIR.0000000000000973"},{"issue":"1","key":"1873_CR43","doi-asserted-by":"publisher","first-page":"e13088","DOI":"10.1111\/obr.13088","volume":"22","author":"EA Silveira","year":"2021","unstructured":"Silveira EA, Kliemann N, Noll M, Sarrafzadegan N, de Oliveira C. Visceral obesity and incident cancer and cardiovascular disease: an integrative review of the epidemiological evidence. Obes Rev. 2021;22(1):e13088. https:\/\/doi.org\/10.1111\/obr.13088. Epub 20200721.","journal-title":"Obes Rev"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-024-01873-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-024-01873-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-024-01873-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T05:10:18Z","timestamp":1721884218000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-024-01873-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1873"],"URL":"https:\/\/doi.org\/10.1186\/s13058-024-01873-y","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"},{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,25]]},"assertion":[{"value":"9 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were performed according to the approval by the institutional review board at the University of Iowa, Iowa City, IA. Mouse experiments were performed according to protocols approved by the Institutional Animal Care and Use Committee at the University of Iowa, Iowa City, IA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"119"}}